Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immuron Ltd ADR (NQ: IMRN )

1.959 +0.029 (+1.50%)
Streaming Delayed Price Updated: 3:37 PM EDT, Sep 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immuron Ltd ADR

< Previous 1 2 3 4 Next >
Immuron hails record monthly sales of Travelan
Immuron Ltd (NASDAQ:IMRN, ASX:IMC) CEO Steve Lydeamore speaks with Proactive following news the company has achieved record monthly sales of its over-the-counter gastrointestinal supplement Travelan®.... 
Via TheNewswire.com
Immuron hails record monthly sales of Travelan
--News Direct-- 
Via News Direct
Immuron achieves record monthly Travelan® sales
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to present at H.C. Wainwright
From Immuron Limited
Via GlobeNewswire
Immuron welcomes launch of Travelan on Amazon US
--News Direct-- 
Via News Direct
FDA Lifts Clinical Hold From Immuron's New Campylobacter ETEC Therapeutic Study
Immuron Limited (NASDAQ: IMRN) has announced that the U.S. 
Via Benzinga
Why Immuron Stock Is Soaring Today
Immuron Ltd (NASDAQ: IMRN) shares are trading higher Monday after the company announced the FDA removed the clinical hold on its new C 
Via Benzinga
Immuron to present at the Military Health System Research Symposium
From Immuron Limited
Via GlobeNewswire
Immuron welcomes launch of Travelan on Amazon US
Immuron Ltd (NASDAQ:IMRN, ASX:IMC) chief commercial officer Flavio Palumbo speaks with Proactive following the news its Travelan product has launched on Amazon US. 
Via TheNewswire.com
Immuron Announces First Patients Enrolled in Travelan® Clinical Study
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to present at Bioshares
From Immuron Limited
Via GlobeNewswire
Why Is Immuron (IMRN) Stock Up 67% Today?
Immuron (IMRN) stock is gaining on Monday thanks to an update from the Food and Drug Administration (FDA) on a clinical hold. 
Via InvestorPlace
Immuron Business Update - Ateria Health launches Juvia™ in Australia
From Immuron Limited
Via GlobeNewswire
Immuron FY23 Sales increase 136% on FY22 Sales
From Immuron Limited
Via GlobeNewswire
Immuron Chairman Transition
From Immuron Limited
Via GlobeNewswire
Immuron Business Update: Letter to Shareholders
From Immuron Limited
Via GlobeNewswire
Immuron Initiates Recruitment of Travelan® Clinical Study
From Immuron Limited
Via GlobeNewswire
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027
Palm Beach, FL – May 9, 2023 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder that attacks the brain’s nerve cells or neurons, which... 
Via FinancialNewsMedia
Topics Intellectual Property
Exposures Intellectual Property
Nasdaq Edges Higher; Six Flags Reports Upbeat Results
U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite turning higher later during the session on Monday. The Dow traded down 0.20% to 33,606.80 while the NASDAQ rose... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Trevena, Inc. (NASDAQ: TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China. 
Via Benzinga
Crude Oil Rises Over 2%; US Wholesale Inventories Unchanged For March
U.S. stocks traded slightly lower midway through trading, with the Nasdaq Composite dropping around 20 points on Monday. The Dow traded down 0.14% to 33,626.85 while the NASDAQ fell 0.18% to 12,212.88.... 
Via Benzinga
Palantir (PLTR) Stock Pops Ahead of Earnings
Palantir (PLTR) stock is a hot topic on Monday as investors prepare for the company to report earnings after today's closing bell. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Is Tupperware Brands (TUP) Stock Down 8% Today?
Tupperware Brands (TUP) stock is taking a beating on Monday after the company said it's exploring strategic alternatives. 
Via InvestorPlace
Why Is Aptorum (APM) Stock Down 16% Today?
Aptorum (APM) stock is falling on Monday after the biopharmaceutical company received a delisting notice from the Nasdaq. 
Via InvestorPlace
Why Bellicum Pharmaceuticals Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket
Gainers Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) gained 105.2% to $0.8001 in pre-market trading. Bellicum Pharmaceuticals 13D filing showed Baker Bros. Advisors reported a 19.99% active stake in... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are a hot topic on Monday as we dive into the biggest winners and losers traders need to know about this morning! 
Via InvestorPlace
Immuron Announces FDA Removed Clinical Hold on New Campylobacter ETEC Therapeutic Paves way for Clinical Trial Initiation
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to present at Coffee Microcaps
From Immuron Limited
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.